Chuck Royce's position in Neogenomics is currently worth $8.51 Million. That's 0.08% of their equity portfolio (351st largest holding). The first Neogenomics trade was made in Q4 2015. Since then Chuck Royce bought shares eleven more times and sold shares on sixteen occasions. The stake costed the investor $6.39 Million, netting the investor a gain of 33% so far.